首页> 外文OA文献 >Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events

【2h】

Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events

机译：活化的重组因子VIIa不应用于难治性静脉曲张破裂出血的患者：大多数无效，昂贵且很少会引起严重不良事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sozio Margaret S.; Chalasani Naga;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种 en_US
中图分类

相似文献

外文文献
中文文献
专利

1. Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events. [J] . Margaret S Sozio, Naga Chalasani Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2014,第5期

机译：活化的重组因子VIIa不应用于难治性静脉曲张破裂出血的患者：它大多无效，昂贵且很少会引起严重的不良事件。
2. A Cerebrovascular Event After Single-Dose Administration of Recombinant Factor VIIa in a Patient with Esophageal Variceal Bleeding [J] . Murat Akyildiz, Ilker Turan, Omer Ozutemiz, Digestive Diseases and Sciences . 2006,第9期

机译：食管静脉曲张破裂出血患者单剂量给予重组因子VIIa后的脑血管事件
3. Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials [J] . BendtsenF., DAmicoG., RuschE., Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2014,第2期

机译：重组因子VIIa对急性静脉曲张破裂出血效果的影响：基于患者的两项两项对照试验的荟萃分析
4. Prevention of first variceal bleeding [C] . P. CALES, N. DIB F. OBERTI Falk Symposium . 2008

机译：预防第一个静脉曲张出血
5. Mutational studies of factor X activation by tissue factor-factor VIIa [D] . Huang, Qiuling 1999

机译：组织因子VIIa激活X因子的突变研究
6. Activated Recombinant Factor VIIa should not be used in patients with refractory variceal bleeding – it is mostly ineffective is expensive and may rarely cause serious adverse events [O] . Margaret S. Sozio, Naga Chalasani -1

机译：活化的重组凝血因子VIIa不应用于难治性静脉曲张破裂出血的患者-它大多无效昂贵且很少会引起严重的不良事件
7. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial [O] . J. Bosch, D. Thabut, A. Albillos, 2008

机译：用于晚期肝硬化患者静脉曲张出血的重组因子VIIa：一项随机对照试验
8. Prolonged Prothrombin Time After Recombinant Activated Factor VII Therapy in Critically Bleeding Trauma Patients Is Associated With Adverse Outcomes. [R] . McMullin, N. R., Wade, C. E., Holcomb, J. B., 2010

机译：重组活化因子VII治疗后严重出血创伤患者的凝血酶原时间延长与不良后果相关。

Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events

著录项

引文网络

相似文献

相关主题

期刊订阅